Pharma disputes, fines, and the work of the CMA
August 25, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Several pharmaceutical firms have lately been fined for unfairly hiking prices over the years, meaning that patients and the NHS …
One-time gene therapy sees promising results in children with AADC deficiency
August 25, 2021Research and Development
A pioneering approach to gene therapy delivery has been published in the European Molecular Biology Organization Journal on Wednesday, wherein …
Generic asthma inhaler to offer NHS significant savings
August 25, 2021Research and Development
Luforbec 100/6 pMDI, the first branded generic alternative to Fostair 100/6 pMDI, to treat adult asthma and severe chronic obstructive …
Protection from COVID-19 vaccines starts to wane within six months
August 25, 2021Research and Development
Researchers are starting to see that protection from the COVID-19 vaccines begins to wane within sixe months of receiving a …
Pfizer to buy Trillium for $2.26 billion
August 25, 2021Research and Development
Pfizer will buy Trillium, a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, for $2.26 billion.Trillium’s …
Sackler family face “substantial risk” of liability over opioid crisis
August 24, 2021Manufacturing and Production
The judge overseeing Purdue Pharma’s bankruptcy said that some members of the Sackler family, owners of OxyContin, face a “substantial …
Schools set to reopen as UK COVID deaths average 100 a day – highest since March
August 24, 2021Manufacturing and Production
According to official data COVID-19 deaths in the UK are averaging at 100 a day, and scientists have warned that …
Pfizer becomes first COVID vaccine to get full FDA approval
August 24, 2021Manufacturing and Production
The FDA has given Pfizer’s COVID-19 vaccine full regulatory approval, making it the first to be officially licensed in the …
EC approves UCB’s plaque psoriasis treatment
August 24, 2021Manufacturing and Production
UCB announced on Tuesday that the European Commission (EC) has granted marketing authorisation for Bimzelx (bimekizumab) for the treatment of …
FDA approves Cara & Vifor’s drug for severe itching in kidney disease patients
August 24, 2021Manufacturing and Production
Vifor Pharma and Cara Therapeutics have gained FDA approval for Korsuva (difelikefalin) for the treatment of moderate-to-severe pruritus associated with …
FDA poised to issue full approval for Pfizer vaccine
August 23, 2021Sales and Marketing
The FDA is on track to issue full approval for its Pfizer vaccine. The New York Times reported that the Pfizer …
India approves world’s first DNA COVID vaccine
August 23, 2021Sales and Marketing
Regulators in India have approved the world’s first DNA vaccine against COVID-19, ZyCoV-D, which has been developed by Cadila Healthcare.The …
Antibody tests offered to UK public for first time
August 23, 2021Sales and Marketing
Antibody tests are to be made widely available to the public for the first time in a new government scheme …
“You are not a cow” – FDA warns against using ivermectin to treat COVID
August 23, 2021Sales and Marketing
The FDA has had to issue a warning against taking ivermectin, the anti-parasitic drug designed for livestock, to treat or …
COVID-19 boosters significantly lower infection risk, study in Israel finds
August 23, 2021Sales and Marketing
A study in Israel has found that a third dose of the Pfizer COVID-19 vaccine significantly improved protection from infection …
Acting FDA Chief ruled out as permanent nominee
August 20, 2021Medical Communications
The administration for US President, Joe Biden, has ruled out nominating Janet Woodcock as permanent head of the FDA, it …
UK approves “first of its kind” antibody cocktail for COVID-19
August 20, 2021Medical Communications
The MHRA has approved a “first of its kind” antibody cocktail developed by Regeneron and Roche to prevent and treat …
UK COVID booster plan for over 50s may be scrapped
August 20, 2021Medical Communications
Plans for a mass rollout of booster COVID vaccines for the over 50s this autumn may be shelved as the …
NICE broadens sapropterin guidance for treating phenylketonuria
August 20, 2021Medical Communications
NICE has extended its approval of sapropterin (also called Kuvan and made by BioMarin) to pregnant women and people aged …
EU approves roxadustat for anaemia associated with chronic kidney disease
August 20, 2021Medical Communications
Europe has approved Evrenzo (roxadustat) for patients with anaemia associated with symptomatic chronic kidney disease. Evrenzo is the first orally …
Latest content
